Elanco Animal Health Inc.

05/27/2026 | Press release | Distributed by Public on 05/27/2026 15:01

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

Elanco Animal Health Incorporated (the "Company") held its annual meeting of shareholders on May 21, 2026. Voting results for each matter submitted to a vote at the 2026 annual meeting are provided below.

Proposal 1. Election of Directors. All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.

Class I Nominees For Against Abstain Broker Non-Votes
Kapila K. Anand 375,459,071 91,840,502 655,918 15,365,167
Paul Herendeen 441,252,058 26,575,629 127,804 15,365,167
Class II Nominees For Against Abstain Broker Non-Votes
Michael Harrington 373,406,333 94,421,261 127,897 15,365,167
Lawrence Kurzius 442,964,897 24,863,542 127,052 15,365,167
Kirk McDonald 440,842,458 26,978,663 134,370 15,365,167

Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026, by the votes set forth in the table below.

For Against Abstain
480,470,647 2,611,450 238,561

Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.

For Against Abstain Broker Non-Votes
383,528,222 84,173,798 253,471 15,365,167
Elanco Animal Health Inc. published this content on May 27, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 27, 2026 at 21:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]